LOINC Code 2012-3: Cancer Ag 27-29 Ql
2012-3 is a LOINC code used to identify Cancer Ag 27-29 Ql in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Cancer Ag 27-29. It is commonly used with the system or sample type Ser/Plas.
What is this code?
LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Cancer Ag 27-29. It is commonly used with the system or sample type Ser/Plas.
When is it used?
- Used in lab systems, EHRs, and clinical data exchange.
- May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
- Status: ACTIVE
- Order vs observation: Both
What it does not mean
- The code identifies the observation or test, not the actual result.
Key facts
- Cancer Ag 27-29 [Presence] in Serum or Plasma
- Cancer Ag 27-29
- B27.9; CA; CA 27-29; CA27.29; Cancer Ag27-29; Carbohydrate antigen; Carbohydrate antigen 27-29; Chemistry; MUC-1 gene associated AG CA 27-29; Oncology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker
Where you may see this code
You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.
Related SNOMED CT concepts
Related observations and tests
Common synonyms
Frequently asked questions
About this content
This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.